Goldman Sachs leads $132 million investment in cancer start-up
A start-up cofounded by Massachusetts General Hospital oncologist Ryan Corcoran and serial entrepreneur Eric Murphy has raised $132 million to put toward new cancer drugs.
News
Alterome raises $132M to take next-gen cancer drugs aimed at the ‘undruggable’ into clinic
With a new $132 million in hand, Alterome Therapeutics is finally divulging what it’s working on. The oncology company will be using its Series B raise to bring two programs — each designed to go after specific cancer-driving mutations — to the clinic within the next year.
Alterome Therapeutics chosen for Best Places to Work San Diego 2023
Alterome is honored to be chosen to be Ranked #2 in the Small Business Category for the Best Places to Work San Diego 2023.
Big4Bio Year in Review San Diego 2022
Alterome Therapeutics has been recognized for its involvement with Life Science Cares and its contributions to the San Diego community.
Mysterious OrbiMed-backed biotech nears $100M in funding, hints at plans to go after ‘undruggable 3.0’
While the biotech put out a press release for its $64 million Series A, led by OrbiMed, it launched without a website and didn’t elaborate on its science beyond “alteration-specific targeted therapies for the treatment of cancer.”
OrbiMed takes point on a new biotech launch, but almost everything remains secret for now
If you missed the news of a new company launch backed by blue-chip investor OrbiMed early Wednesday morning, that was by design. Alterome Therapeutics quietly emerged from stealth with $64 million in its Series A…